ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Ponatinib modulates the metabolic profile of obese mice by inhibiting adipose tissue macrophage inflammation

Lin, Zhuomiao; Lin, Xiaochun; Lai, Ying; Han, Congcong; Fan, Xinran; Tang, Jie; Mo, Shiqi; Su, Jiahui; Liang, Sijia; Shang, Jinyan; Lv, Xiaofei; Guo, Siwan; Pang, Ruiping; Zhou, Jiaguo; Zhang, Tingting*; Zhang, Feiran*广州医学院; 中山大学; 1; 5
Frontiers in Pharmacology2022-11-15DOI: 10.3389/fphar.2022.1040999
4被引21阅读
引用收藏
分享

摘要

Obesity-induced metabolic syndrome is a rapidly growing conundrum, reaching epidemic proportions globally. Chronic inflammation in obese adipose tissue plays a key role in metabolic syndrome with a series of local and systemic effects such as inflammatory cell infiltration and inflammatory cytokine secretion. Adipose tissue macrophages (ATM), as one of the main regulators in this process, are particularly crucial for pharmacological studies on obesity-related metabolic syndrome. Ponatinib, a multi-targeted tyrosine kinase inhibitor originally used to treat leukemia, has recently been found to improve dyslipidemia and atherosclerosis, suggesting that it may have profound effect on metabolic syndrome, although the mechanisms underlying have not yet been revealed. Here we discovered that ponatinib significantly improved insulin sensitivity in leptin deficient obese mice. In addition to that, ponatinib treatment remarkably ameliorated high fat diet-induced hyperlipidemia and inhibited ectopic lipid deposition in the liver. Interestingly, although ponatinib did not reduce but increase the weight of white adipose tissue (WAT), it remarkably suppressed the inflammatory response in WAT and preserved its function. Mechanistically, we showed that ponatinib had no direct effect on hepatocyte or adipocyte but attenuated free fatty acid (FFA) induced macrophage transformation from pro-inflammatory to anti-inflammatory phenotype. Moreover, adipocytes co-cultured with FFA-treated macrophages exhibited insulin resistance, while pre-treat these macrophages with ponatinib can ameliorate this process. These results suggested that the beneficial effects of ponatinib on metabolic disorders are achieved by inhibiting the inflammatory phenotypic transformation of ATMs, thereby maintaining the physiological function of adipose tissue under excessive obesity. The data here not only revealed the novel therapeutic function of ponatinib, but also provided a theoretical basis for the application of multi-target tyrosine kinase inhibitors in metabolic diseases.

学科与关键词

关键词
ponatinibadipose tissue macrophagesobesitymetabolic dysfunctiontyrosine kinase inhibitors
相关
加载中…
  • Re ducing ob esity and inflammation in mice with organically-derivatized polyoxovanadate clusters
    Chen, Kun*; Dai, Guoyong; Liu, Shengqiu; Wei, Yongge*CHINESE CHEMICAL LETTERS, 2023, 34(5): 107638.被引 5
  • Antibiotic Azithromycin inhibits brown/beige fat functionality and promotes obesity in human and rodents
    Yu, Jian; Chen, Xin; Zhang, Yuanjin; Cui, Xiangdi; Zhang, Zhe; Guo, Wenxiu; Wang, Dongmei; Huang, Shengbo; Chen, Yanru; Hu, Yepeng; Zhao, Cheng; Qiu, Jin; Li, Yu; Meng, Meiyao; Guo, Mingwei; Shen, Fei; Zhang, Mengdi; Zhou, Ben; Gu, Xuejiang; Wang, Jiqiu; Wang, Xin*; Ma, Xinran*; Xu, Lingyan*2022, 12(1): 1187-1203.被引 5
  • Nutritional activities of luteolin in obesity and associated metabolic diseases: an eye on adipose tissues
    Zhang, Zhixin; Wang, Jiahui; Lin, Yan; Chen, Juan; Liu, Jian*; Zhang, Xian*Critical Reviews in Food Science and Nutrition, 2022.被引 6
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Pharmacology
发表日期
2022-11-15
卷期
第 13 卷
页码
1040999
DOI
10.3389/fphar.2022.1040999
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
National Key R&D Program of China; National Natural Science Foundation of China [2021YFA0805100]; National Natural Science Foundation of Guangdong [81930106, U21A20342, 82003744, 82170545, 81903598, 82073839, 91739104, 82204384]; GuangDong Basic and Applied Basic Research Foundation [2019A1515011295]; High-level Health Team Foundation of Zhuhai (2018) [2019A1515110872]; High Talents Scientific Research Foundation of Zhongshan School Medicine

作者

  • L

    Lin, Zhuomiao (第一作者)

    sun yat sen univ

  • L

    Lin, Xiaochun

    1 · sun yat sen univ

查看全部 16 位作者收起作者
  • L

    Lai, Ying

    sun yat sen univ

  • H

    Han, Congcong

    sun yat sen univ

  • F

    Fan, Xinran

    sun yat sen univ

  • T

    Tang, Jie

    sun yat sen univ

  • M

    Mo, Shiqi

    sun yat sen univ

  • S

    Su, Jiahui

    sun yat sen univ

  • L

    Liang, Sijia

    5 · sun yat sen univ

  • S

    Shang, Jinyan

    sun yat sen univ

  • L

    Lv, Xiaofei

    sun yat sen univ

  • G

    Guo, Siwan

    sun yat sen univ

  • P

    Pang, Ruiping

    sun yat sen univ

  • Z

    Zhou, Jiaguo

    guangzhou med univ · sun yat sen univ · 5

  • Z

    Zhang, Tingting (通讯)

    sun yat sen univ

  • Z

    Zhang, Feiran (通讯)

    5 · sun yat sen univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417